CELZ: Creative Medical Technology Holdings, Inc. Stock

by  •  • Comments Off on CELZ: Creative Medical Technology Holdings, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 6.21
Enterprise Value ($M) 2.75
Book Value ($M) 10.34
Book Value / Share 7.62
Price / Book 0.60
NCAV ($M) 9.90
NCAV / Share 7.30
Price / NCAV 0.63

Profitability (mra)
Return on Invested Capital (ROIC) -0.51
Return on Assets (ROA) -0.35
Return on Equity (ROE) -0.36

Liquidity (mrq)
Quick Ratio 27.64
Current Ratio 27.65

Balance Sheet (mrq) ($M)
Current Assets 10.27
Assets 10.72
Liabilities 0.37
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.01
Operating Income -5.62
Net Income -5.29
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -8.03
Cash from Investing 3.45
Cash from Financing -0.27

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
05-26 13G/A Markey John 0.00 -100.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-04-29 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Mark One)
2024-03-22 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One)
2023-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One)
2023-08-11 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One)
2023-05-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One)

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-01 10 543 1.84
2024-04-30 516 611 84.45
2024-04-29 358 368 97.28
2024-04-26 1,331 2,786 47.77

(click for more detail)

Similar Companies
CDTX – Cidara Therapeutics, Inc. CDXC – ChromaDex Corporation
CELU – Celularity Inc. CERE – Cerevel Therapeutics Holdings, Inc.
CGEN – Compugen Ltd.


Financial data and stock pages provided by
Fintel.io